RecruitingNot ApplicableNCT04635020

Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group

A Prospective Randomised Trial Comparing Selective Laser Trabeculoplasty (SLT) and iStent Trabecular Micro-bypass Stent Implantation Combined With Cataract Surgery in Exfoliation Glaucoma

Sponsor

Helsinki University Central Hospital

Enrollment

285 participants

Start Date

Oct 1, 2020

Study Type

INTERVENTIONAL

Conditions

Cataract Exfoliation Glaucoma

Summary

The purpose of the study is to investigate the efficacy of an iStent trabecular microbypass stent compared to selective laser trabeculoplasty in combination with cataract surgery in eyes with exfoliation glaucoma (EXF)

Eligibility

Min Age: 50 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Cataract surgery, a procedure called SLT-laser, and others for people with cataract and exfoliation glaucoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 50 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.